A detailed history of Oakworth Capital, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Oakworth Capital, Inc. holds 523 shares of DHR stock, worth $122,931. This represents 0.01% of its overall portfolio holdings.

Number of Shares
523
Previous 458 14.19%
Holding current value
$122,931
Previous $114,000 27.19%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$239.25 - $280.76 $15,551 - $18,249
65 Added 14.19%
523 $145,000
Q2 2024

Jul 19, 2024

BUY
$235.51 - $267.98 $24,964 - $28,405
106 Added 30.11%
458 $114,000
Q1 2024

Apr 22, 2024

SELL
$224.58 - $256.19 $3,368 - $3,842
-15 Reduced 4.09%
352 $87,000
Q4 2023

Jan 30, 2024

BUY
$185.1 - $233.13 $13,142 - $16,552
71 Added 23.99%
367 $84,000
Q3 2023

Oct 31, 2023

SELL
$233.08 - $265.59 $20,277 - $23,106
-87 Reduced 22.72%
296 $73,000
Q2 2023

Jul 28, 2023

SELL
$224.99 - $256.14 $112,944 - $128,582
-502 Reduced 56.72%
383 $91,000
Q1 2023

May 02, 2023

BUY
$239.75 - $277.0 $123,711 - $142,932
516 Added 139.84%
885 $223,000
Q4 2022

Feb 03, 2023

BUY
$241.42 - $282.29 $1,689 - $1,976
7 Added 1.93%
369 $97,000
Q3 2022

Oct 31, 2022

BUY
$247.06 - $1507.4 $5,929 - $36,177
24 Added 7.1%
362 $94,000
Q2 2021

Jul 20, 2021

BUY
$225.08 - $271.69 $22,508 - $27,169
100 Added 42.02%
338 $91,000
Q1 2021

Apr 30, 2021

BUY
$212.38 - $245.9 $8,495 - $9,836
40 Added 20.2%
238 $54,000
Q3 2020

Nov 09, 2020

BUY
$177.16 - $215.33 $11,515 - $13,996
65 Added 48.87%
198 $43,000
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $51,452 - $55,658
-380 Reduced 74.07%
133 $19,000
Q1 2018

May 09, 2018

BUY
$92.16 - $103.8 $4,515 - $5,086
49 Added 10.56%
513 $51,000
Q3 2017

Nov 08, 2017

BUY
$79.29 - $88.45 $36,790 - $41,040
464
464 $39,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Oakworth Capital, Inc. Portfolio

Follow Oakworth Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.